Iproteos Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Investors
-
1
Iproteos General Information
Description
Developer of neurological therapy designed to treat cardiovascular and central nervous systems as well as epilepsy. The company's therapy specializes in the research and development of third-generation drugs, such as protein-protein interactions (PPIs), enabling medical professionals to treat schizophrenia, epilepsy, pediatric cancer and other neurological disorders.
Contact Information
Website
www.iproteos.comCorporate Office
- Baldiri Reixac, 10
- Barcelona Science Park
- 08028 Barcelona
- Spain
Corporate Office
- Baldiri Reixac, 10
- Barcelona Science Park
- 08028 Barcelona
- Spain
Iproteos Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
9. Merger/Acquisition | 28-May-2020 | Completed | Generating Revenue | |||
8. Early Stage VC (Series A) | 15-Jul-2018 | Completed | Generating Revenue | |||
7. Grant | 29-May-2017 | Completed | Generating Revenue | |||
6. Seed Round | 25-Oct-2016 | Completed | Pre-Clinical Trials | |||
5. Equity Crowdfunding | 26-Sep-2016 | Completed | Pre-Clinical Trials | |||
4. Seed Round | 03-Jun-2015 | Completed | Startup | |||
3. Equity Crowdfunding | 01-Nov-2014 | Completed | Startup | |||
2. Grant | 01-Jan-2014 | $686K | $144K | Completed | Startup | |
1. Capitalization | 01-Jan-2012 | $144K | $144K | Completed | Startup |
Iproteos Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Ordinary Shares | ||||||||
Ordinary Shares |
Iproteos Comparisons
Industry
Financing
Details
Iproteos Competitors (24)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Minoryx | Venture Capital-Backed | Barcelona, Spain | ||||
Sangamo Therapeutics | Formerly VC-backed | Richmond, CA | ||||
Forge Biologics | Formerly VC-backed | Grove City, OH | ||||
Ultragenyx Pharmaceutical | Formerly VC-backed | Novato, CA | ||||
Lumos Pharma | Formerly VC-backed | Austin, TX |
Iproteos Former Investors (5)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
ASCIL Biopharm | Other | Minority | ||
Caixa Capital Risc | Venture Capital | Minority | ||
Horizon 2020 SME Instrument | Government | |||
Kinled Holding | Family Office | Minority | ||
Ministerio de Economía, Industria y Competitividad | Government |
Iproteos FAQs
-
When was Iproteos founded?
Iproteos was founded in 2011.
-
Where is Iproteos headquartered?
Iproteos is headquartered in Barcelona, Spain.
-
What industry is Iproteos in?
Iproteos’s primary industry is Drug Discovery.
-
Is Iproteos a private or public company?
Iproteos is a Private company.
-
What is Iproteos’s current revenue?
The current revenue for Iproteos is
. -
How much funding has Iproteos raised over time?
Iproteos has raised $5.19M.
-
Who are Iproteos’s investors?
ASCIL Biopharm, Caixa Capital Risc, Horizon 2020 SME Instrument, Kinled Holding, and Ministerio de Economía, Industria y Competitividad have invested in Iproteos.
-
Who are Iproteos’s competitors?
Minoryx, Sangamo Therapeutics, Forge Biologics, Ultragenyx Pharmaceutical, and Lumos Pharma are some of the 24 competitors of Iproteos.
-
When was Iproteos acquired?
Iproteos was acquired on 28-May-2020.
-
Who acquired Iproteos?
Iproteos was acquired by Accure Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »